Literature DB >> 22381458

Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection.

Basirudeen Syed Ahamed Kabeer1, Paulkumaran Paramasivam, Alamelu Raja.   

Abstract

OBJECTIVE: This study aimed to compare the levels of TB-antigen specific Interferon gamma (IFN-γ) and IFN-γ inducible protein (IP)-10 in culture of whole blood samples from healthy controls (HC) and healthy household contacts (HHC).
METHODOLOGY: A total of 386 study subjects, which included 186 HC and 200 HHC, were recruited. QuantiFERON-TB Gold in-tube (QFT-IT) assay was employed to measure IFN-γ levels. IP-10 levels were measured in the supernatants collected from QFT-IT tubes. Tuberculin skin test was also performed.
RESULTS: The levels of TB antigen specific IFN-γ and IP-10 were significantly higher in HHC compared to HC. There was no significant difference observed between positivity of QFT-IT and IP-10 in HC and HHC. The positivity of TST was significantly lower in subjects <17 year, when compared to IP-10 (p<0.005). The reduced cut-off point 0.22IU/ml significantly increased the positivity of QFT-IT among children with high risk for latent TB infection (LTBI).
CONCLUSIONS: Measurement of TB antigen specific IFN-γ and IP-10 can be potential markers for the detection of LTBI.
Copyright © 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381458      PMCID: PMC3350596          DOI: 10.1016/j.jinf.2012.02.013

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  30 in total

Review 1.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.

Authors:  Delia Goletti; Alamelu Raja; Basirudeen Syed Ahamed Kabeer; Camilla Rodrigues; Archana Sodha; Ornella Butera; Stefania Carrara; Guy Vernet; Christophe Longuet; Giuseppe Ippolito; Satheesh Thangaraj; Marc Leportier; Enrico Girardi; Philippe Henri Lagrange
Journal:  J Infect       Date:  2010-05-12       Impact factor: 6.072

3.  Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians.

Authors:  A Lalvani; P Nagvenkar; Z Udwadia; A A Pathan; K A Wilkinson; J S Shastri; K Ewer; A V Hill; A Mehta; C Rodrigues
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

Review 4.  Specific immune-based diagnosis of tuberculosis.

Authors:  P Andersen; M E Munk; J M Pollock; T M Doherty
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

Review 5.  Lymphocyte traffic control by chemokines.

Authors:  B Moser; P Loetscher
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

Review 6.  Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities.

Authors:  D A Lewinsohn; M L Gennaro; L Scholvinck; D M Lewinsohn
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

7.  Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?

Authors:  Delia Goletti; Alamelu Raja; Basirudeen Syed Ahamed Kabeer; Camilla Rodrigues; Archana Sodha; Stefania Carrara; Guy Vernet; Christophe Longuet; Giuseppe Ippolito; Satheesh Thangaraj; Marc Leportier; Enrico Girardi; Philippe Henri Lagrange
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

8.  IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.

Authors:  Basirudeen Syed Ahamed Kabeer; Alamelu Raja; Balambal Raman; Satheesh Thangaraj; Marc Leportier; Giuseppe Ippolito; Enrico Girardi; Philippe Henri Lagrange; Delia Goletti
Journal:  BMC Infect Dis       Date:  2011-05-19       Impact factor: 3.090

9.  Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?

Authors:  Mohammed Ahmed Yassin; Roberta Petrucci; Kefyalew Taye Garie; Gregory Harper; Isabel Arbide; Melkamsew Aschalew; Yared Merid; Zelalem Kebede; Amin Ahmed Bawazir; Nabil Mohamed Abuamer; Luis Eduardo Cuevas
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

10.  Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia.

Authors:  Philip C Hill; Roger H Brookes; Annette Fox; Katherine Fielding; David J Jeffries; Dolly Jackson-Sillah; Moses D Lugos; Patrick K Owiafe; Simon A Donkor; Abdulrahman S Hammond; Jacob K Otu; Tumani Corrah; Richard A Adegbola; Keith P W J McAdam
Journal:  Clin Infect Dis       Date:  2004-03-16       Impact factor: 9.079

View more
  8 in total

1.  Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.

Authors:  Maddineni Prabhavathi; Basirudeen Syed Ahamed Kabeer; Anbarasu Deenadayalan; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2014-12-11       Impact factor: 3.402

2.  Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis.

Authors:  Shu-Jin Guo; Liu-Qun Jia; Qian-Jing Hu; Hong-Yu Long; Cai-Shuang Pang; Fu-Qiang Wen
Journal:  Int J Clin Exp Med       Date:  2014-01-15

3.  Benzylideneacetophenone derivatives attenuate IFN-γ-induced IP-10/CXCL10 production in orbital fibroblasts of patients with thyroid-associated ophthalmopathy through STAT-1 inhibition.

Authors:  Sung-Hee Lee; Seul Ye Lim; Ji Ha Choi; Jae-Chul Jung; Seikwan Oh; Koung Hoon Kook; Youn-Hee Choi
Journal:  Exp Mol Med       Date:  2014-06-13       Impact factor: 8.718

4.  Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.

Authors:  Mary Ann De Groote; Michael Higgins; Thomas Hraha; Kirsten Wall; Michael L Wilson; David G Sterling; Nebojsa Janjic; Randall Reves; Urs A Ochsner; Robert Belknap
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

5.  Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis.

Authors:  Noëmi R Meier; Thomas Volken; Marc Geiger; Ulrich Heininger; Marc Tebruegge; Nicole Ritz
Journal:  Front Pediatr       Date:  2019-05-29       Impact factor: 3.418

6.  Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.

Authors:  Ida Wergeland; Jörg Assmus; Anne Ma Dyrhol-Riise
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

7.  Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase.

Authors:  Ana Paula Santos; Raquel da Silva Corrêa; Marcelo Ribeiro-Alves; Ana Carolina Oliveira Soares da Silva; Thiago Thomaz Mafort; Janaína Leung; Geraldo Moura Batista Pereira; Luciana Silva Rodrigues; Rogério Rufino
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

Review 8.  Electrochemical Biosensors for Cytokine Profiling: Recent Advancements and Possibilities in the Near Future.

Authors:  Nirmita Dutta; Peter B Lillehoj; Pedro Estrela; Gorachand Dutta
Journal:  Biosensors (Basel)       Date:  2021-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.